Come up with a name for your new list and we'll add to it:
Bionure raised a round of funding on May 17, 2018. Investors include
Alta Life Sciences.
Bionure is a biotech company developing first - in - class SGK agonists for the treatment of different neurodegenerative disorders for which no treatment options are nowadays available.…